-+ 0.00%
-+ 0.00%
-+ 0.00%

XERIS BIOPHARMA - COMPLAINTS ALLEGE INFRINGEMENT OF '502 PATENT BY GENERIC DICHLORPHENAMIDE PRODUCTS - SEC FILING

Reuters·10/14/2026 11:09:00

Please log in to view news